"Onderdeel van Treant Zorggroep"

During the past decade, Scheper Ziekenhuis conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Scheper Ziekenhuis" #1 sponsor was "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 2 trials, followed by "University Medical Center Groningen" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Cerenis Therapeutics, SA" with 1 trials sponsored and "Erasmus Medical Center" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Scheper Ziekenhuis" #1 collaborator was "Aesculap AG" with 1 trials as a collaborator, "Baxter Healthcare Corporation" with 1 trials as a collaborator, "Central European Myeloma Study Group" with 1 trials as a collaborator, "Cisbio Bioassays" with 1 trials as a collaborator and "DSMM (Deutsche Studiengruppe Multiples Myelom)" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Scheper Ziekenhuis" are "Coronary Artery Disease" (2 trials), "Abdominal Pain" (1 trials), "Acute Coronary Syndrome" (1 trials), "Acute Coronary Syndromes" (1 trials) and "Angina Pectoris" (1 trials). Many other conditions were trialed in "Scheper Ziekenhuis" in a lesser frequency.

Most popular intervention types in "Scheper Ziekenhuis" are "Drug" (4 trials), "Device" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "1 or 2 cycle(s) HDM (High Dose Melphalan)" (1 trials), "2 cycles of Bortezomib, Lenalidomide, Dexamethasone (VRD)" (1 trials), "Aspirin" (1 trials), "Bortezomib, Melphalan, Prednisone (VMP)" (1 trials) and "CER-001" (1 trials). Other intervention names were less common.

The vast majority of trials in "Scheper Ziekenhuis" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Scheper Ziekenhuis". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Scheper Ziekenhuis, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Scheper Ziekenhuis, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".